Evidence map›Paper›PMID 38528493›Full record

ArticleBMC oral health2024

The effect of various inhaled asthma medications on the color stability of paediatric dental restorative materials.

Merve Candan, Murat Ünal

Open access · goldAbstract read
In one paragraph

Article in BMC oral health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Merve CandanDepartment of Paediatric Dentistry, Faculty of Dentistry, Eskişehir Osmangazi University, Eskişehir, Turkey. dt.mervecandan@gmail.com.ORCID http://orcid.org/0000-0002-9839-871X
Murat ÜnalDepartment of Paediatric Dentistry, Faculty of Dentistry, Sivas Cumhuriyet University, Sivas, Turkey.
Eskişehir Osmangazi University · TRSivas Cumhuriyet Üniversitesi · TR

Funding

Sivas Cumhuriyet University Scientific Research Projects (CUBAP) Project number: DIS-230
6 · The paper itself

Abstract

backgroundThe purpose of the study is to analyse the effects of different inhaled asthma medications (IAMs) on the color change of dental restorative materials (DRMs).

methodsIn total, 192 samples were taken from six different DRMs: [Filtek Z550 (nanohybrid composite), Fusio Liquid Dentin (Self-adhering flowable composite), Filtek Ultimate (nanofilled flowable composite), Dyract XP (compomer), Fuji II LC (resin-modified glass ionomer), Fuji IX Fast (self-cured-packable glass ionomer), (n = 32)]. After the initial color values (CIELab) of DRMs were measured by using a spectrophotometer, each sample was exposed to the same IAMs via nebulizer according to the four different inhaled therapies and measurements were repeated on the 7th & 21st days.

resultsIn all IAM groups, DRM with the least amount of ΔE was nanohybrid composite, while the highest ΔE was found in Fuji II LC. Among all experimental groups, only Fuji II LC which was administered the combined medication, exceeded the clinically unacceptable threshold (ΔE = 3.3) on 7th & 21st days.

conclusionsConsequently, important factors affecting the susceptibility to color stability are the type of IAMs, the administration time-dosage, and the type of DRMs.

Indexed as

Composite ResinsDental Restoration, PermanentAcrylic ResinsChildColorDental MaterialsGlass Ionomer CementsHumansMaterials TestingSilicon DioxideAcrylic ResinsComposite ResinsDental Materialsglass ionomerGlass Ionomer CementsSilicon DioxideAsthma medicationColor stabilityDental restorative materialsNebulizationPediatric dentistry

Identifiers

PMID38528493
PMCPMC11289941
OpenAlexW4393196818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.